DK166683B1 - Substitueret carboxylsyreresinat, dets fremstilling og anvendelse samt farmaceutisk praeparat indeholdende resinatet - Google Patents

Substitueret carboxylsyreresinat, dets fremstilling og anvendelse samt farmaceutisk praeparat indeholdende resinatet Download PDF

Info

Publication number
DK166683B1
DK166683B1 DK011884A DK11884A DK166683B1 DK 166683 B1 DK166683 B1 DK 166683B1 DK 011884 A DK011884 A DK 011884A DK 11884 A DK11884 A DK 11884A DK 166683 B1 DK166683 B1 DK 166683B1
Authority
DK
Denmark
Prior art keywords
resinate
formula
resin
active substance
acid
Prior art date
Application number
DK011884A
Other languages
Danish (da)
English (en)
Other versions
DK11884A (da
DK11884D0 (da
Inventor
Satish Chandra Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK11884D0 publication Critical patent/DK11884D0/da
Publication of DK11884A publication Critical patent/DK11884A/da
Application granted granted Critical
Publication of DK166683B1 publication Critical patent/DK166683B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/44—Preparation of metal salts or ammonium salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DK011884A 1983-01-12 1984-01-11 Substitueret carboxylsyreresinat, dets fremstilling og anvendelse samt farmaceutisk praeparat indeholdende resinatet DK166683B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH14783A CH655507B (ro) 1983-01-12 1983-01-12
CH14783 1983-01-12

Publications (3)

Publication Number Publication Date
DK11884D0 DK11884D0 (da) 1984-01-11
DK11884A DK11884A (da) 1984-07-13
DK166683B1 true DK166683B1 (da) 1993-06-28

Family

ID=4180317

Family Applications (1)

Application Number Title Priority Date Filing Date
DK011884A DK166683B1 (da) 1983-01-12 1984-01-11 Substitueret carboxylsyreresinat, dets fremstilling og anvendelse samt farmaceutisk praeparat indeholdende resinatet

Country Status (41)

Country Link
US (1) US4510128A (ro)
EP (1) EP0122219B1 (ro)
JP (1) JPS59134759A (ro)
KR (1) KR900006747B1 (ro)
AR (1) AR240310A1 (ro)
AT (2) AT391467B (ro)
AU (1) AU570230B2 (ro)
BE (1) BE898649A (ro)
CA (1) CA1218077A (ro)
CH (1) CH655507B (ro)
CS (1) CS269954B2 (ro)
DD (1) DD218373A5 (ro)
DE (2) DE3474152D1 (ro)
DK (1) DK166683B1 (ro)
DZ (1) DZ593A1 (ro)
EG (1) EG16562A (ro)
ES (1) ES528770A0 (ro)
FI (1) FI82682C (ro)
FR (1) FR2542735B1 (ro)
GB (1) GB2134529B (ro)
GR (1) GR79793B (ro)
HK (1) HK90390A (ro)
HU (1) HU190750B (ro)
IE (1) IE56545B1 (ro)
IL (1) IL70660A (ro)
IT (1) IT1177501B (ro)
LU (1) LU85171A1 (ro)
MA (1) MA20000A1 (ro)
MC (1) MC1564A1 (ro)
MT (1) MTP943B (ro)
NL (1) NL8400098A (ro)
NO (1) NO162862C (ro)
NZ (1) NZ206815A (ro)
OA (1) OA07628A (ro)
PH (1) PH21795A (ro)
PL (1) PL142737B1 (ro)
PT (1) PT77932B (ro)
RO (1) RO88481A (ro)
SE (1) SE457959B (ro)
ZA (1) ZA84212B (ro)
ZW (1) ZW484A1 (ro)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
ES8604955A1 (es) * 1985-11-08 1986-03-16 Covex Sa Procedimiento para la preparacion de resinatos de la (-) eburnamenina-14-(15h)-ona
AU608114B2 (en) * 1987-12-23 1991-03-21 Smith Kline & French Laboratories Limited Compounds
GB8730010D0 (en) * 1987-12-23 1988-02-03 Smith Kline French Lab Compounds
US5230885A (en) * 1987-12-23 1993-07-27 Smith Kline & French Laboratories Limited Polystyrene anion exchange polymer pharmaceutical composition
CH675537A5 (ro) * 1988-03-25 1990-10-15 Ciba Geigy Ag
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
ATE87476T1 (de) * 1988-11-10 1993-04-15 Ciba Geigy Ag Fluessige orale formulierung.
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition
GB8911719D0 (en) * 1989-05-22 1989-07-05 Smith Kline French Lab Compounds
GB8913700D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
GB8913699D0 (en) * 1989-06-14 1989-08-02 Smith Kline French Lab Compounds
US5079001A (en) * 1989-11-03 1992-01-07 Ciba-Geigy Corporation Liquid oral formulation of diclofenac
GB8928278D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
SE9004129D0 (sv) * 1990-12-21 1990-12-21 Pharmacia Lkb Biotech Anion exchanger
WO1993000873A1 (en) * 1991-07-03 1993-01-21 Sano Corporation Composition and method for transdermal delivery of diclofenac
DE60232290D1 (de) * 2001-04-09 2009-06-25 Rohm & Haas Kontrollierte Auflösung von Wirkstoffen
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
US20050036977A1 (en) * 2003-08-11 2005-02-17 Dilip Gole Taste-masked resinate and preparation thereof
WO2006061700A2 (en) * 2004-12-06 2006-06-15 Themis Laboratories Private Limited Rapid disintegrating taste masked compositions and a process for its preparations
CA2645855C (en) 2006-03-16 2015-02-03 Tris Pharma, Inc. Modified release formulations containing drug-ion exchange resin complexes
US7799347B2 (en) 2006-09-07 2010-09-21 Chondrex Inc. Endotoxin-adsorbent for the prevention and treatment of autoimmune diseases
AU2009298112B2 (en) * 2008-10-02 2015-11-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Administration of an adsorbent polymer for treatment of systemic inflammation
CA2794171C (en) 2010-03-24 2018-07-03 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
CA2880456A1 (en) 2012-08-15 2014-02-20 Tris Pharma, Inc. Methylphenidate extended release chewable tablet
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
WO2020106735A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
EP3930702A1 (en) 2019-03-01 2022-01-05 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB857193A (en) * 1957-03-14 1960-12-29 Clinical Products Ltd Resin-drug compounds
GB823000A (en) * 1957-10-03 1959-11-04 Clinical Products Ltd Resin-drug compounds
GB869149A (en) * 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3316282A (en) * 1965-02-08 1967-04-25 Squibb & Sons Inc Anion exchange resin complex of a cycloborate ester of a steroid
SE366296B (ro) * 1967-12-20 1974-04-22 Ciba Geigy Ag
CH519476A (de) * 1968-03-30 1972-02-29 Hoechst Ag Verfahren zur Herstellung von Salzen von Acylamino-alkylbenzolsulfonyl-harnstoffen mit Anionenaustauschern
US3926864A (en) * 1971-06-21 1975-12-16 Ionics Ion exchange membranes having a macroporous surface area
GB1423694A (en) * 1973-07-10 1976-02-04 Beecham Group Ltd Pharmaceutical compositions
US4058491A (en) * 1975-02-11 1977-11-15 Plastomedical Sciences, Inc. Cationic hydrogels based on heterocyclic N-vinyl monomers
FR2352547A1 (fr) * 1976-05-25 1977-12-23 Viridis Ets Nouvelle resine anionique a action hypocholesterolemiante, son procede de preparation et compositions therapeutiques la contenant
US4217421A (en) * 1977-06-27 1980-08-12 Rohm And Haas Company Anion exchange resins prepared from crosslinked polystyrenesulfonylchloride
US4380590A (en) * 1978-09-19 1983-04-19 Rohm And Haas Company Emulsion copolymer cation exchange resins
IT1106718B (it) * 1978-12-21 1985-11-18 Alfa Farmaceutici Spa Composizioni a base di resine anioniche salificate farmacologicamente attive
US4207399A (en) * 1979-03-14 1980-06-10 Rohm And Haas Company Methylquinoline high polymer based on quaternary ammonium polymers
US4302548A (en) * 1980-05-22 1981-11-24 Rohm And Haas Company Production of ion exchange resins, the resins so produced and ion exchange processes using them

Also Published As

Publication number Publication date
DE3400491C2 (ro) 1988-11-10
HU190750B (en) 1986-10-28
CS17884A2 (en) 1989-10-13
ES8504849A1 (es) 1985-05-01
BE898649A (fr) 1984-07-11
ATA784A (de) 1990-04-15
JPH0257058B2 (ro) 1990-12-03
GB8400251D0 (en) 1984-02-08
SE8400098D0 (sv) 1984-01-10
DK11884A (da) 1984-07-13
PL245656A1 (en) 1985-01-02
NO840090L (no) 1984-07-13
GB2134529A (en) 1984-08-15
AU570230B2 (en) 1988-03-10
EG16562A (en) 1991-12-30
MTP943B (en) 1984-06-05
MC1564A1 (fr) 1984-11-12
AR240310A1 (es) 1990-03-30
FI840069A0 (fi) 1984-01-09
IT8447527A0 (it) 1984-01-10
PT77932B (en) 1986-07-22
DK11884D0 (da) 1984-01-11
ZW484A1 (en) 1984-08-08
KR900006747B1 (ko) 1990-09-20
ES528770A0 (es) 1985-05-01
CA1218077A (en) 1987-02-17
JPS59134759A (ja) 1984-08-02
ZA84212B (en) 1984-08-29
US4510128A (en) 1985-04-09
IE840049L (en) 1984-07-12
IL70660A0 (en) 1984-04-30
LU85171A1 (de) 1984-10-24
EP0122219A2 (de) 1984-10-17
NO162862B (no) 1989-11-20
FI82682B (fi) 1990-12-31
PT77932A (en) 1984-02-01
DE3400491A1 (de) 1984-07-12
SE8400098L (sv) 1984-07-13
DZ593A1 (fr) 2004-09-13
DE3474152D1 (en) 1988-10-27
IT1177501B (it) 1987-08-26
PL142737B1 (en) 1987-11-30
EP0122219B1 (de) 1988-09-21
HK90390A (en) 1990-11-09
ATE37378T1 (de) 1988-10-15
PH21795A (en) 1988-02-29
IL70660A (en) 1987-08-31
KR840007562A (ko) 1984-12-08
GR79793B (ro) 1984-10-31
DD218373A5 (de) 1985-02-06
RO88481A (ro) 1986-01-30
NL8400098A (nl) 1984-08-01
CH655507B (ro) 1986-04-30
CS269954B2 (en) 1990-05-14
NZ206815A (en) 1986-08-08
EP0122219A3 (en) 1985-05-08
OA07628A (fr) 1985-05-23
IE56545B1 (en) 1991-08-28
GB2134529B (en) 1986-09-24
SE457959B (sv) 1989-02-13
AT391467B (de) 1990-10-10
FI840069A (fi) 1984-07-13
FR2542735A1 (fr) 1984-09-21
FR2542735B1 (fr) 1986-04-18
MA20000A1 (fr) 1984-10-01
HUT34151A (en) 1985-02-28
AU2323084A (en) 1984-07-19
FI82682C (fi) 1991-04-10
NO162862C (no) 1990-02-28

Similar Documents

Publication Publication Date Title
DK166683B1 (da) Substitueret carboxylsyreresinat, dets fremstilling og anvendelse samt farmaceutisk praeparat indeholdende resinatet
US20230248676A1 (en) Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
US6685964B1 (en) Opioid analgesics with controlled active substance release
AU606353B2 (en) Pharmaceutical formulations
EP1162975A1 (en) Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin
JPS63258406A (ja) 持続放出製剤
WO1988007369A1 (en) Pharmaceutical formulations
JPS6327362B2 (ro)
NO140526B (no) Vernevisiranording for sikkerhetshjelm
KR20100035167A (ko) 제산제로서 사용되는 혼합 금속 화합물
IE46594B1 (en) Copolymers of methyl methacrylate and nitrogen-containing acrylate or methacrylate esters
WO1993024124A1 (en) Compositions based on histamine h2-receptor antagonists and cationic exchangers complexes
US4041153A (en) Methods and pharmaceutical preparation for the treatment of hypercholesterolaemia
Suhagiya et al. Taste masking by ion exchange resin and its new applications: A review
US6004546A (en) Pharmaceutical composition containing bismuth-polyacrylic acid compounds
WO2013031935A1 (ja) 安定な医薬組成物
CN101259140B (zh) 一种治疗胃炎、胃溃疡及十二指肠溃疡的复方药物及其制备方法
CA2757023A1 (en) 24-hour extended-release metoclopramide
JPH01316324A (ja) コレステロール低下剤

Legal Events

Date Code Title Description
PUP Patent expired